ALMIB — Amoeba SA Share News
0.000.00%
Last trade - 00:00Brief: Amoeba Announces Results Of A Laboratory Safety And Efficacy Study
Brief: Amoeba H1 Net Loss Widens To 4.5 Million Euros
Brief: Amoeba Announces That Its Regulatory Dossier Reaches The Last Phase Of Assessment
Brief: Amoeba Announces Establishment Of EUR 6 Million Bond Financing Line
Brief: Amoeba And Earthwise Announce Positive Results Of Industrial Test In U.S.
Brief: Amoeba Informs Of Release Of Biocidal Products Committee Opinion
Brief: Amoeba Announces Its Project Of Restructuring Its Site Of Lyon Chassieu
Brief: AMOEBA Willaertia Magna C2c Maky Not Approved
Brief: Amoeba FY Net Loss Widens To 6.2 Million Euros
Brief: Amoeba and Conidia validate effect of Willaertia Magna as biocontrol agent
Brief: Amoeba signs a letter of intent with H2O facilities
Brief: Amoeba receives financing worth 20 million euros from the European Investment Bank
Brief: Amoeba H1 operating loss widens to 3.1 million euros
Brief: Amoeba signs a letter of intent with Momar Inc. for distribution of Biomeba on a new territory in the U.S.
Brief: Amoeba and Viscus Biologics announce common program
Brief: Amoeba's shareholders have decided to replace the dual structure of management by a board of directors
Brief: Amoeba signs letter of intent for the distribution of Biomeba in Romania
Brief: Amoeba FY net loss widens to 5.8 million euros
Brief: Amoeba starts research and development tests in U.S.